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Abstract: The kinetics of changes in the abundance of mRMAs emcoding various
cytokines (interferon-ƒÁ (IFN-ƒÁ), tumor necrosis factor-ƒ¿ (TNF-ƒ¿), interleukin-4 (IL-4),
and (IL-6)) and Fas, Fas ligand were measured by reverse transcription-PCR at various
sites in both susceptible C57BL/6 and resistant BALB/c mice infected with the Fukaya
Toxoplasma gondii (T. gondii). The abundance of transcripts encoding IFN-ƒÁ, TNF-ƒ¿, and
IL-6 increased markedly from two weeks after infection, reaching a plateau at four weeks,
in the brains of C57BL/6 mice (p<0.05). In spleen, the abundance of IFN-ƒÁ and TNF-ƒ¿
mRNAswas increased two weeks after infection and then decreased in both mouse strains.
Neutralization of endogenous IFN-ƒÁ markedly increased parasite number in the brain of
C57BL/6 mice, whereas injection of exogenous IFN-ƒÁ had no effect. This observation in-
dicates that endogenous IFN-ƒÁ is essential but not sufficient for inhibition of T. gondii
growth in vivo. No changes in the abundance of IL-4 mRNAwere observed in the brain or
spleen of either mouse strains. The abundance of Fas mRNAwas slightly higher (p<0.05)
in the resistant BALB/c mice than in the susceptible C57BL/6 mice and the abundance of
Fas ligand mRNAwas slightly higher (p<0.05) in the susceptible C57BL/6 mice than in the
resistant BALB/c mice. This observation suggests that Fas may contribute to a protective
role in resistant BALB/c mice and that increased Fas ligand expression in brain of suscep-
tible C57BL/6 mice may result from inflammation of toxoplasmic encephalitis.
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INTRODUCTION
Towplasma gondii (T. gondii) is an intracellular parasite that causes toxoplasmic en-
cephalitis, a life threatening infection in immunocompromised individuals (Luft, et al., 1984;
Luft and Remington, 1988). Inbred C57BL/6 (H-2b) mice show a higher mortality rate and a
larger number of cysts in the brain than inbred BALB/c (H-2d) mice after infection with
Fukaya strain. Genes of the major histocompatibility complex (MHC), especially of the H-2
region, as well as non-MHC linked genes, regulate the susceptibility to toxoplasmic en-
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cephalitis and influence cyst formation (Brown and McLeod, 1990; Deckert-Schluter, et al.,
1994; McLeod, et al., 1993). To explore the mechanisms of immune responses of host to
Toxoplasma infection in susceptible C57BL/6 and resistant BALB/c mice, we evaluated roles
of cytokines (interleukin-4 (IL-4), IL-6, tumor necrosis factor-a (TNF-a), and interfe-
ron-f (IFN~r)) implicated in the host immune response (Gazzinelli, et al., 1993a; Hunter, et
al., 1993; Hunter, et al., 1992; Schluter, et al., 1993; Suzuki and Joh, 1994) in toxoplasmic
encephalitis by measuring mRNAs of these cytokines. The roles of Fas and Fas ligand, which
mediate cytotoxicity by apoptosis, were also evaluated.
MATERIALS AND METHODS
Mice.
Inbred BALB/c and C57BL/6 mice (ChaYles River, Yokohama, Japan) were housed in
the Laboratory Animal Center for Biomedical Research at Nagasaki University School of
Medicine.
T. gondii and infection.
An avirulent Fukaya strain of T. gondii was obtained from Y. Suzuki (Jikei Medical
University, Tokyo, Japan). Cysts of this strain were prepared from C57BL/6 mice six weeks
after oral infection with 20 cysts. C57BL/6 and BALB/c mice infected orally with 20 cysts of
T. gondii were then sacrificed by asphyxiation with ethyl ether, one, two, four, or six weeks
after infection. Spleen and brain were collected for the determination of the abundance of
Fas, Fas ligand, ZL-^i, IL-6, IFN-f and TNF-a mRNAs.
Reverse transcription (RT)-PCR for Fas, Fas ligand and cytokine mRNAs.
Total RNA was isolated with TRIzol reagent (Life Technologies, Gaithersburg, MD),
and one pg was subjected to CDNA synthesis in a total volume of 20 j«l with an RNA PCR
kit (TaKaRa, Shiga, Japan). The reaction mixture that contained 10 mM Tris-HCl (pH 8.3),
50 mM KC1, 5mM MgCl2, 1 mM of each deoxynucleoside triphosphate, 20 U of RNase in-
hibitor, 5 U of avian myeloblastosis virus reverse transcriptase XL, and 2.5 mM random
nine-nucleotide oligomers, was incubated at 30°C for 10 min, 50°C for 30 min, 100°C for 5
min, and 4°C for 10 min. The reaction mixture was then diluted to 100//1 with
double-distilled H20, and 5/d of the diluted CDNA were subjected to PCR with primers
specific for IL-4, IL-6, TNF-a, IFN-f, Fas or Fas ligand. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) DNA was also amplified as a standard to ensure that CDNA con-
centrations in different reaction mixtures were approximately equal. The band intensities of
PCR products after electrophoresis were measured with an IPLab Gel densitometer (Signal
Analytical Corp. Vienna, VA). Data were expressed as an S/G ratio ((optical density of sample
(S)/opical density of GAPDH (G)) x 100). Contamination of total RNA with genomic DNA was
examined by attempting to amplify cytokine genes from total RNA by conventional PCR; no
cytokine genomic DNA was detected in one fig of total RNA.
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N eutralization of endogenous IFN- if or treatment with exogenous IFN- y.
BALB/c or C57BL/6 mice were injected intraperitoneally with one mg of a monoclonal
antibody (mAb) (R4-6A2) to mouse IFN-7- five and 12 days after infection with 20 cysts of
the Fukaya strain of T, gondii. Other animals were injected with 5000 U of mouse IFN-7-
(supernatant of cultured IFN-7- producing cells (X63 BCMG Neo (PUC) mIFN-r)) (Relink,
et al., 1991) on day five and 12 after infection. Control mice were injected intraperitoneally
with phosphate-buffered saline. After six weeks of infection, T. gondii numbers were de-
termined by quantitative competitive PCR (QC-PCR) (Luo, et al., 1995).
Statistical analysis.
Statistical evaluations of differences between means of experimental groups were de-
termined by paired student's t-test.
RESULTS
Cytokine mRNA.abundance in the brain.
The abundance of transcripts encoding IFN-7-, TNF-a, IL-4, and IL-6 in the
brains of BALB/c and C57BL/6 mice was measured by RT-PCR one, two, four, and six
weeks after infection. IFN-7- mRNA was detected in small amounts in both C57BL/6 and
BALB/c mice one week after infection, and subsequently increased in abundance only in
C57BL/6 mice (£<0.05) (Fig. 1, Fig. 2A). The abundance of TNF-a mRNAwas low at one
week and moderately increased at two weeks after infection in both strains of mice, and
thereafter increased further in C57BL/6 mice (£<0.05) and decreased in BALB/c mice (Fig.
2B). The abundance of IL-6 mRNA remained low in the brains of BALB/c and C57BL/6
mice for two weeks after infection, and thereafter increased in C57BL/6 mice (£<0.05) , but
not in BALB/c mice (Fig. 2C). No significant difference of IL-4 mRNA abundance was








Fig. 1. Abundance of IFN-j" mRNA in brains of BALB/c and C57BL/6 mice at two and four
weeks after infection with T. gondii. Lane 1, molecular size marker (Hae IE digest of
$6X174); Lanes 2 to 4, BALB/c mice two weeks after infection; lanes 5 to 7, C57BL/6
mice two weeks after infection; lanes 8 to 10, BALB/c four weeks after infection; lanes
ll to 13, C57BL/6 mice four weeks after infection. Upper panel shows the IFN-j
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Fig. 2. Time courses of changes in the abundance of mRNAs encoding IFN-y (A),
TNF-tf (B), IL-6 (C), and IL-4 (D) in the brains of BALB/c (D) and
C57BL/6 (O) mice after infection with T. gondii. Data are means ± SD of
three animals and are expressed as the ratio of cytokine mRNA signal to
GAPDH mRNAsignal x 100 (S/G ratio).
Cytokine mRNAabundance in spleen.
Because of the blood brain barrier, the immune response to pathogens in the brain may
differ from that in other organs. We therefore examined cytokine mRNA abundance in the
spleen of mice infected with T. gondii. The abundance of IFN-f (Fig. 3A) and TNF-a (Fig.
3B) mRNAs was low one week after infection, increased slightly at two weeks, and thereafter
decreased in both BALB/c and C57BL/6 mice. Transcripts encoding IL-6 (Fig. 3C) or IL-4
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Fig. 3. Kinetics of changes in the abundance of mRNAs encoding IFN-?- (A), TNF-a
(B), IL-6 (C), and IL-4 (D) in the spleens of BALB/c (D) and C57BL/6 (O)
mice after infection with T. gondii. Data are means ± SD of three animals.
Effects of neutralization of endogenous IFN- f or injection of exogenous IFN- f.
The role of IFN-7- in the immune response to T. gondii infection wa£ further investi-
gated by injecting mice intraperitoneally with a mAb to IFN-r or IFN-r itself five and 12
days after infection. Injection of the mAb to IFN-f markedly increased the number of T.
gondii in the brains of C57BL/6 mice (£<0.05), but not in those of BALB/c mice, at six
weeks after infection (Fig. 4). In contrast, injection of IFN-^ did not affect T. gondii num-
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Fig. 4. Numbers of T. gondii in the brains of C57BL/6 (open
bars) and BALB/c (closed bars) mice treated with a mAb
to IFN-f, IFN-f itself, or phosphate-buffered saline
(control) five and 12 days after infection. Data are means
± SD of three animals.
Abundance of Fas and Fas ligand mRNAsin brain and spleen.
A decrease in the number of lymphocytes in the spleen in response to T. gondii infec-
tion was previously shown to be markedly greater in susceptible C57BL/6 mice than in
resistant A/J mice (McLeod, et al., 1989). To investigate the mechanism of apoptotic cell
death during the immune response to T. gondii infection, we measured the abundance of Fas
and Fas ligand mRNAs in the brain and spleen of C57BL/6 and BALB/c mice. The abun-
dance of Fas mRNA showed a small increase with time in the brain of BALB/c mice,
whereas it tended to be lower and more variable in the brain of C57BL/6 mice (£<0.05) (Fig.
5A). The amount of Fas mRNAin spleen was also greater in BALB/c mice than in C57BL/6
mice (£<0.05) (Fig. 5B). The abundance of Fas ligand mRNAin brain was slightly higher in
C57BL/6 mice than in BALB/c mice throughout the period observed (£<0.05) (Fig. 5C). Low
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Fig. 5. Kinetics of changes in the abundance of mRNAs encoding Fas (A and B) and
Fas ligand (C and D) in the brain (A and C) and spleen (B and D) of BALB/c
O andC57BL/6 (O) mice after infection with T. gondii. Data are means ±
SD of three animals.
DISCUSSION
We have now demonstrated a markedly higher abundance of IFN-j mRNA in the
brain in C57BL/6 mice than in BALB/c mice. These transcripts may be produced by CD4+ or
CD8+ T lymphocytes, because larger numbers of these cells are present in the parenchyma
and perivascular and meningeal infiltrates of susceptible mice (Brown, et aL, 1995), or they
maybe produced by natural killer cells (Schluter, et al., 1993). Neutralization of endogenous
IFN-r markedly increased T. gondii numbers in the brains of C57BL/6 mice, although in-
jection of exogenous murine IFN-j had no effect on T. gondii number in either mouse
strain. These observations indicate that endogenous IFN-?- is essential but not sufficient for
inhibition of T. gondii growth in vivo. Furthermore, other group (Shirahata. et al., 1986)
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detected differences in serum IFN-? concentration after infection with the relatively aviru-
lent S-273 strain of T. gondii between resistant BALB/c and susceptible C57BL/6 mice at
early stage. Detailed mechanisms of IFN-j mediated genetic control of susceptibility to T.
gondii infection remains to be elucidated. Although the presence of TNF-a in serum and the
brain of mice infected with T. gondii has been described by several groups (Brown, et al.,
1995; Deckert-Schluter, et al., 1994; Freund, et al., 1992; Gazzinelli, et al., 1993a; Hunter,
et al, 1993; Hunter, et al., 1992; Roberts, et al., 1995; Schluter, et al., 1993), the role of this
cytokine in the pathogenesis of toxoplasmic encephalitis remains to be elucidated. The
presence of TNF-a mRNAin the brains of susceptible C57BL/6 mice, but not of resistant
BALB/c mice^ was demonstrated after 30 days of chronic infection with the Me49 strain of
T. gondii (Brown, et al., 1995; Freund, et al., 1992). We detected large amounts of TNF-a
mRNAin the brains of susceptible G57BL/6 mice from two weeks after infection. This may
reflect differences in the ability of these mice to produce TNF-a in response to inflamma-
tory stimuli or differences in these stimuli.
The concentration of IL-6 was shown to be increased in serum and cerebrospinal fluid
of SCID and CB-17 mice infected with the DX strain of T. gondii (Schluter, et al., 1993).
Increased amounts of IL-6 mRNAwere previously described in the brains of C57BL/10 Sc
SN mice infected with the Beverley strain of T. gondii (Hunter, et al., 1992), and in the
brains of SCID (Hunter, et al., 1993) and C57BL/6 (Gazzinelli, et al,, 1993a) mice infected
with the Me49 strain of T. gondii. This cytokine markedly enhances the intracellular repli-
cation of T. gondii after the invasion of macrophages prepared from Swiss-Webster mice,
and it impairs the IFN-f--mediated toxoplasmacidal activity of macrophages when both
cytokines are either administered together/or sequentially/ before infection (Beaman, et al.,
1994). The survival of SCID mice infected with T. gondii was prolonged by treatment with
antibodies to IL-6 (Hunter, et al., 1993). In central nervous system, microglia are believed to
be derived from bone marrow monocytes that populate the central nervous system during
fetal development. Thes£ glial cells appear to be functionally equivalent to macrophages in
other tissues. Thus, our results suggest that the increased abundance of IL-6 mRNAin the
brain of susceptible mice may inhibit microglial cell-mediated killing of T. gondii, even in
the presence of high concentrations of IFN-y and TNF-a.
Thl and Th2 subsets of CD4+ T cells play differing roles in the immune response to
parasitic infections. Th2 CD4+ T cells produce cytokines (IL-4 and IL-10) that inhibit the
ability of IFN-j to activate macrophages to limit the growth of Trypanosoma cruzi and T.
gondii (Sher, et al., 1992). We could not detect any changes in IL-4 mRNAabundance in
the brain or spleen of either strain of mouse, consistent with the observation of Brown et al
(Brown, et al., 1995). Other groups detected an increased abundance of IL-10 mRNAin the
brains of SCID mice and susceptible mice (C3H/HeJ, BIO. RKDB, BALB/c-H-2dm2,
C57BL/6) infected with T. gondii (Brown, et al., 1995; Hunter, et al., 1993). Neutralization of
IL-10 increased the survival time of infected SCID mice (Hunter, et al., 1993). On the other
hand, neutralization of IL-12 decreased the survival time of the mice (Gazzinelli, et al.,
1993b). Furthermore exogenous IL-12 was demonstrated protective effect in SCID mice
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infected with T. gandii The combination of IL-12 and TNF-a induced the production of
IFN-7 from whole spleen cells of infected mice to a greater extent than that observed with
spleen cells from uninfected mice (Htmter, et al., 1994).
The productions of IFN-f, TNF-a, IL~6 were comparable to the number of T.
gondii in brain. We did not find any significant difference in T. gondii load in brain and other
organs at day one, two, three, and seven after infection between BALB/c and C57BL/6 mice
when T. gondii number was examined by using quantitative competitive PCR method. This
may reflect that cytokine production by brain is. host response to T. gondii infection.
The immune responses of brain may be different from those of other organs because of
the blood brain barrier. We examined the cytokine productions in spleen after infection of T.
gondii. No significant difference could be found between two mouse strains. This suggests
that cytokine production in spleen did not correlate with cyst formation in brain.
We previously showed that cytotoxic CD4+ T cells effectively kill T. gondii-Mected
human melanoma cells (Yang, et al., 1995). Cytotoxic Thl CD4+ T cells may induce cell
death by triggering a Fas-dependent apoptdtic pathway (Stalder, et al., 1994). In present
study, the abundance of Fas mRNAwas slightly higher in resistant BALB/c mice than in
susceptible C57BL/6 mice and the abundance of Fas ligand mRNA was slightly higher in
susceptible C57BL/6 mice than in resistant BALB/c mice. This observation suggests that Fas
maycontribute to a protective role in resistant BALB/c mice and that increased Fas ligand
expression in brain of susceptible C57BL/6 may result from or in inflammation of toxoplasmic
encephalitis.
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